Korea approves Green Cross' Hunterase

Green Cross Corp. (Yongin-si, South Korea) said Korea's FDA approved Hunterase to treat Hunter syndrome (mucopolysaccharidosis II). Hunterase is a recombinant iduronate-2-sulfatase (IDS). ...